Pfizer seeks U.S. authorization for vaccine booster retooled for Omicron Pfizer Inc and German partner BioNTech said on Monday they had sought U.S. authorization for a COVID-19 vaccine booster retooled to target the Omicron variant, and would have doses available to ship immediately after regulatory clearance. Reuters Reuters

...

Omicron-specific Covid booster shots are just weeks away. Here’s who will—and won’t—be eligible

Newly updated Covid booster shots designed to target omicron’s BA.5 subvariant should be available within in the next three weeks. That begs an important question: Who’s going to be eligible to get them?

The short answer: Anyone ages 12 and up who has completed a primary vaccination series, a Centers for Disease Control and Prevention spokesperson tells CNBC Make It. It’s unlikely to matter whether you’ve received any other booster doses or not before, the spokesperson says — but if you’re unvaccinated, you won’t eligible for the updated formula until you complete a primary series with the existing Covid vaccines.

The longer answer is somewhat more complex, because it depends on which booster shots get approved and when. ...

Factbox: Latest on the worldwide spread of the coronavirus Japanese Prime Minister Fumio Kishida has tested positive for COVID-19, forcing him to cancel a planned trip to Tunisia to attend a key conference on African development, a person close to him said on Sunday. Reuters Reuters

...

Serious adverse events rare after COVID-19 boosters in young kids A related study in South Korea shows waning vaccine effectiveness in teens. CIDRAP

Data collected from two vaccine safety surveillance programs in the first 10 weeks of administration of third doses of the Pfizer/BioNTech COVID-19 to US children aged 5 to 11 years show that serious adverse events were rare.